Cooper Cos. (COO) Unit Acquires Smiths Medical's Wallace

November 7, 2016 6:06 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

The Cooper Companies, Inc. (NYSE: COO) announced that CooperSurgical has acquired Wallace, the in-vitro fertilization (IVF) segment of Smiths Medical, a division of Smiths Group plc, for a purchase price of approximately $168 million subject to customary closing adjustments. Wallace reported sales of approximately $29 million in the last twelve months. Excluding non-recurring items and deal-related amortization, the transaction is expected to be approximately $0.10 accretive to earnings per share in fiscal 2017.

Commenting on the transaction, Robert S. Weiss, Cooper's president and chief executive officer said, “This acquisition is a great strategic fit with our existing IVF portfolio as Wallace brings the gold standard of embryo transfer catheters along with several other premier products such as oocyte retrieval needles. The addition of these products further strengthens our IVF portfolio which is sold into fertility clinics worldwide.”



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Management Comments, Mergers and Acquisitions

Related Entities

Earnings, Definitive Agreement

Add Your Comment